article Editorial. (2023). The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia. Union of pediatricians of Russia.
Chicago Style (17th ed.) Citationarticle Editorial. The FDA Has Approved Bozutinib for Children with Chronic Myelogenous Leukemia. Union of pediatricians of Russia, 2023.
MLA (9th ed.) Citationarticle Editorial. The FDA Has Approved Bozutinib for Children with Chronic Myelogenous Leukemia. Union of pediatricians of Russia, 2023.
Warning: These citations may not always be 100% accurate.